Healthcare Associated Infection
Conditions
Brief summary
This is a controlled open label efficacy study of Aionx antimicrobial surface for the prevention of healthcare-associated infections.
Detailed description
The study is an open label controlled efficacy trial of Aionx patented antimicrobial surface for the prevention of healthcare-associated infections (HAIs). It will take place at Penn State Hershey. Half of the single occupancy rooms of the 5th and 7th floor will be assigned to contain the antimicrobial surface at five locations: bed rails, overbed table, door handles, counter, and arm rests of bedside chair. The remaining rooms will serve as controls. Data on HAIs will be gathered for all the patients admitted to the rooms during the duration of the study. After 45 days the rooms will be flipped so that test rooms become controls and control rooms become test rooms. The duration of the study will be for a minimum of 90 days.
Interventions
DEVICEAntimicrobial Surface
Antimicrobial Surface
Sponsors
Aionx, Inc.
Study design
Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Admission to a single occupancy room in a participating floor at Hershey Medical Center
Exclusion criteria
* Refusal to participate in the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Healthcare-Associated Infections | 90 days | Healthcare-Associated Infections |
Secondary
| Measure | Time frame |
|---|---|
| 30-day Readmission for infection | 90 days |
Contacts
Primary ContactJose A Stoute, M.D.
Outcome results
None listed